Trial Profile
Phase I clinical trial of preoperative arterial immuno-embolization with OK-432 / fibrinogen / lipiodol for resectable primary hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary) ; Fibrinogen (Primary) ; Picibanil (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 17 Jun 2019 Status changed from recruiting to completed.
- 22 Jun 2017 New trial record